Expression and activity of antioxidants in the brain in progressive supranuclear palsy

被引:36
作者
Cantuti-Castelvetri, I
Keller-McGandy, CE
Albers, DS
Beal, MF
Vonsattel, JP
Standaert, DG
Augood, SJ
机构
[1] Massachusetts Gen Hosp, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Charlestown, MA 02129 USA
[3] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA
关键词
progressive supranuclear palsy; parkinsonism; tau; superoxide dismutase; neurodegeneration; oxidative stress;
D O I
10.1016/S0006-8993(02)02244-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent evidence implicates oxidative stress in the pathophysiology of progressive supranuclear palsy (PSP). Thus, we undertook a study of the activity and localization of two essential antioxidant systems (superoxide dismutase [SOD] enzymes and total glutathione) in the human post-mortem PSP and control brain. Marked increases in SOD1 (Cu/ZnSOD) activity and glutathione levels were measured within most PSP brain regions examined, whereas, only the subthalamic nucleus exhibited a significant increase (+68%) in SOD2 (MnSOD) activity. Two additional cases with mild pathological abnormalities were studied. The first (case A) may represent an example of an asymptomatic PSP case, while the second (case B) had mild pathological abnormalities consistent with typical PSP. In case A, only the STN had elevated levels of SOD activity, in the absence of an increase in tissue glutathione content. In case B, SOD activities and tissue glutathione content were elevated in several regions. Immunolocalization of the SOD1 and SOD2 proteins in paraffin-embedded tissue sections revealed a marked increase in the density of SOD immunopositive profiles (particularly glia) in the typical PSP brain, particularly within the white matter. Together, our data argues strongly in favor of the involvement of oxidative stress in the etiology and progression of PSP, and suggests that deficit in SOD or glutathione metabolism are not causative. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:170 / 181
页数:12
相关论文
共 51 条
[41]   ALTERATIONS IN GLUTATHIONE LEVELS IN PARKINSONS-DISEASE AND OTHER NEURODEGENERATIVE DISORDERS AFFECTING BASAL GANGLIA [J].
SIAN, J ;
DEXTER, DT ;
LEES, AJ ;
DANIEL, S ;
AGID, Y ;
JAVOYAGID, F ;
JENNER, P ;
MARSDEN, CD .
ANNALS OF NEUROLOGY, 1994, 36 (03) :348-355
[42]   STRATEGIES OF ANTIOXIDANT DEFENSE [J].
SIES, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 215 (02) :213-219
[43]   HISTOCHEMICAL EVALUATION OF GLUTATHIONE IN BRAIN [J].
SLIVKA, A ;
MYTILINEOU, C ;
COHEN, G .
BRAIN RESEARCH, 1987, 409 (02) :275-284
[44]  
SLOT JW, 1986, LAB INVEST, V55, P363
[45]   PROGRESSIVE SUPRANUCLEAR PALSY - HETEROGENEOUS DEGENERATION INVOLVING BRAIN STEM BASAL GANGLIA + CEREBELLUM WITH VERTICAL GAZE + PSEUDOBULBAR PALSY NUCHAL DYSTONIA + DEMENTIA [J].
STEELE, JC ;
OLSZEWSKI, J ;
RICHARDSON, JC .
ARCHIVES OF NEUROLOGY, 1964, 10 (04) :333-&
[46]   Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy [J].
Swerdlow, RH ;
Golbe, LI ;
Parks, JK ;
Cassarino, DS ;
Binder, DR ;
Grawey, AE ;
Litvan, I ;
Bennett, JP ;
Wooten, GF ;
Parker, WD .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (04) :1681-1684
[47]  
TARAKHOVSKII AM, 1985, B EXP BIOL MED+, V99, P108
[48]   Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders [J].
Tarnopolsky, MA ;
Beal, MF .
ANNALS OF NEUROLOGY, 2001, 49 (05) :561-574
[49]   Progressive supranuclear palsy: A clinicopathological study of 21 cases [J].
Verny, M ;
Jellinger, KA ;
Hauw, JJ ;
Bancher, C ;
Litvan, I ;
Agid, Y .
ACTA NEUROPATHOLOGICA, 1996, 91 (04) :427-431
[50]   FASTING-INDUCED DEPLETION OF GLUTATHIONE IN THE AGING MOUSE [J].
VOGT, BL ;
RICHIE, JP .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (02) :257-263